105 related articles for article (PubMed ID: 26821530)
1. Combined Angiogenesis and Proliferation Markers' Expressions as Long-Term Prognostic Factors in Renal Cell Cancer.
Virman JP; Bono P; Luukkaala TH; Sunela KL; Kujala PM; Kellokumpu-Lehtinen PL
Clin Genitourin Cancer; 2016 Aug; 14(4):e283-9. PubMed ID: 26821530
[TBL] [Abstract][Full Text] [Related]
2. Novel Angiogenesis Markers as Long-Term Prognostic Factors in Patients With Renal Cell Cancer.
Lampinen AM; Virman JP; Bono P; Luukkaala TH; Sunela KL; Kujala PM; Saharinen P; Kellokumpu-Lehtinen PI
Clin Genitourin Cancer; 2017 Feb; 15(1):e15-e24. PubMed ID: 27554585
[TBL] [Abstract][Full Text] [Related]
3. VEGFR3 and CD31 as prognostic factors in renal cell cancer.
Virman J; Bono P; Luukkaala T; Sunela K; Kujala P; Kellokumpu-Lehtinen PL
Anticancer Res; 2015 Feb; 35(2):921-7. PubMed ID: 25667475
[TBL] [Abstract][Full Text] [Related]
4. pT1 clear cell renal cell carcinoma: a study of the association between MIB-1 proliferative activity and pathologic features and cancer specific survival.
Cheville JC; Zincke H; Lohse CM; Sebo TJ; Riehle D; Weaver AL; Blute ML
Cancer; 2002 Apr; 94(8):2180-4. PubMed ID: 12001115
[TBL] [Abstract][Full Text] [Related]
5. Renal cell carcinoma MIB-1, Bax and Bcl-2 expression and prognosis.
Kallio JP; Hirvikoski P; Helin H; Luukkaala T; Tammela TL; Kellokumpu-Lehtinen P; Martikainen PM
J Urol; 2004 Dec; 172(6 Pt 1):2158-61. PubMed ID: 15538222
[TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of ploidy, MIB-1 proliferation marker, and p53 in renal cell carcinoma.
Kramer BA; Gao X; Davis M; Hall M; Holzbeierlein J; Tawfik O
J Am Coll Surg; 2005 Oct; 201(4):565-70. PubMed ID: 16183495
[TBL] [Abstract][Full Text] [Related]
7. Neovascularity as a prognostic marker in renal cell carcinoma.
Bauman TM; Huang W; Lee MH; Abel EJ
Hum Pathol; 2016 Nov; 57():98-105. PubMed ID: 27436827
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical analysis with multiple antibodies in search of prognostic markers for clear cell renal cell carcinoma.
Phuoc NB; Ehara H; Gotoh T; Nakano M; Yokoi S; Deguchi T; Hirose Y
Urology; 2007 May; 69(5):843-8. PubMed ID: 17482919
[TBL] [Abstract][Full Text] [Related]
9. Expression level of vascular endothelial growth factor receptor-2 in radical nephrectomy specimens as a prognostic predictor in patients with metastatic renal cell carcinoma treated with sunitinib.
Terakawa T; Miyake H; Kusuda Y; Fujisawa M
Urol Oncol; 2013 May; 31(4):493-8. PubMed ID: 21478036
[TBL] [Abstract][Full Text] [Related]
10. IMPORTANCE OF APOPTOSIS MARKERS (MDM2, BCL-2 AND Bax) IN CONVENTIONAL RENAL CELL CARCINOMA.
Saker Z; Tsintsadze O; Jiqia I; Managadze L; Chkhotua A
Georgian Med News; 2015 Dec; (249):27-33. PubMed ID: 26719546
[TBL] [Abstract][Full Text] [Related]
11. Conventional (clear cell) renal carcinoma metastases have greater bcl-2 expression than high-risk primary tumors.
Lee CT; Genega EM; Hutchinson B; Fearn PA; Kattan MW; Russo P; Reuter VE
Urol Oncol; 2003; 21(3):179-84. PubMed ID: 12810203
[TBL] [Abstract][Full Text] [Related]
12. Impact of p53, MIB-1 and PECAM-1 expression on the prognosis of urothelial carcinoma of the renal pelvis.
García-Tello A; Angulo JC; Andrés G; Ramón de Fata F; Sánchez-Chapado M; López JI
Actas Urol Esp; 2014 Oct; 38(8):506-14. PubMed ID: 24702909
[TBL] [Abstract][Full Text] [Related]
13. Expression of bcl-2, p53 oncoprotein, and proliferating cell nuclear antigen in renal cell carcinoma.
Sejima T; Miyagawa I
Eur Urol; 1999; 35(3):242-8. PubMed ID: 10072628
[TBL] [Abstract][Full Text] [Related]
14. Vimentin over-expression and carbonic anhydrase IX under-expression are independent predictors of recurrence, specific and overall survival in non-metastatic clear-cell renal carcinoma: a validation study.
Ingels A; Hew M; Algaba F; de Boer OJ; van Moorselaar RJ; Horenblas S; Zondervan P; de la Rosette JJ; Pilar Laguna Pes M
World J Urol; 2017 Jan; 35(1):81-87. PubMed ID: 27207480
[TBL] [Abstract][Full Text] [Related]
15. Bcl-2 protein expression is associated with p27 and p53 protein expressions and MIB-1 counts in breast cancer.
Tsutsui S; Yasuda K; Suzuki K; Takeuchi H; Nishizaki T; Higashi H; Era S
BMC Cancer; 2006 Jul; 6():187. PubMed ID: 16839413
[TBL] [Abstract][Full Text] [Related]
16. Prognostic role of tumor necrosis, microvessel density, vascular endothelial growth factor and hypoxia inducible factor-1alpha in patients with clear cell renal carcinoma after radical nephrectomy in a long term follow-up.
Minardi D; Lucarini G; Filosa A; Milanese G; Zizzi A; Di Primio R; Montironi R; Muzzonigro G
Int J Immunopathol Pharmacol; 2008; 21(2):447-55. PubMed ID: 18547492
[TBL] [Abstract][Full Text] [Related]
17. Cancer stem cell markers predict a poor prognosis in renal cell carcinoma: a meta-analysis.
Cheng B; Yang G; Jiang R; Cheng Y; Yang H; Pei L; Qiu X
Oncotarget; 2016 Oct; 7(40):65862-65875. PubMed ID: 27588469
[TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of platelet-derived growth factor receptor-β expression in localized clear cell renal cell carcinoma.
Shim M; Song C; Park S; Choi SK; Cho YM; Kim CS; Ahn H
J Cancer Res Clin Oncol; 2015 Dec; 141(12):2213-20. PubMed ID: 26215891
[TBL] [Abstract][Full Text] [Related]
19. Expression of potential molecular markers in renal cell carcinoma: impact on clinicopathological outcomes in patients undergoing radical nephrectomy.
Sakai I; Miyake H; Takenaka A; Fujisawa M
BJU Int; 2009 Oct; 104(7):942-6. PubMed ID: 19388989
[TBL] [Abstract][Full Text] [Related]
20. Prognostic factors in a prospective series of papillary renal cell carcinoma.
Gontero P; Ceratti G; Guglielmetti S; Andorno A; Terrone C; Bonvini D; Faggiano F; Tizzani A; Frea B; Valente G
BJU Int; 2008 Sep; 102(6):697-702. PubMed ID: 18489525
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
